Correlation of HER-2/Neu Protein Expression and HER2 Gene Amplification with Clinical Morphological Parameters of Nonsmall Cell Lung Cancer

Bulletin of Experimental Biology and Medicine

Volumn 157, Issue 6, 2014, Pages 789-793

  Kobyakov, D S ^a,b   Avdalyan, A M ^a,b   Bobrov, I P ^a,b   Bychkova, E Yu ^a,b   Lazarev, A F ^a,b   Lushnikova, E L ^a,b   Nepomnyashchikh, L M ^a,b  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^b INSTITUTE OF REGIONAL PATHOLOGY AND PATHOMORPHOLOGY   (Russian Federation)

Author keywords

CEP17; HER2; immunohistochemistry; in situ Hybridization; nonsmall cell lung cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER STAGING; CHROMOSOME 17; FEMALE; GENE AMPLIFICATION; HISTOGENESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; RECEPTOR, ERBB-2;

EID: 84922002860     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-014-2668-9     Document Type: Article

References (13)

1. F. Cappuzzo, M. Varella-Garcia, H. Shigematsu, et al., J. Clin. Oncol., 23, No. 22, 5007-5018 (2005).
2. G. Cox, M. Vyberg, B. Melgaard, et al., Int. J. Cancer, 92, No. 4, 480-483 (2001).
3. T. J. Grob, I. Kannengiesser, M. C. Tsourlakis, et al., Mod. Pathol., 25, No. 12, 1566-1573 (2012).
4. F. R. Hirsch, M. Varella-Garcia, W. A. Franklin, et al., Brit. J. Cancer, 86, No. 9, 1449-1456 (2002).
5. C. C. Hsieh, K. C. Chow, H. J. Fahn, et al., Ann. Thorac. Surg., 66, No. 4, 1159-1164 (1998).
6. J. Ma, M. Gao, Y. Lu, et al., J. Pathol., 210, No. 2, 205-213 (2006).
7. C. Marchio, M. B. Lambros, P. Gugliotta, et al., J. Pathol., 219, No. 1, 16-24 (2009).
8. H. Nakamura, H. Saji, A. Ogata, et al., Int. J. Cancer, 103, No. 1, 61-66 (2003).
9. I. Panagiotou, S. N. Georgiannos, E. Tsiambas, et al., Asian Pac. J. Cancer Prev., 13, No. 12, 6311-6318 (2012).
10. G. Pelosi, B. Del Curto, P. Dell’Orto, et al., Int. J. Cancer, 113, No. 1, 101-108 (2005).
11. L. Sobin, M. Gospodarowicz, and C. Wittekind, TNM Classification of Malignant Tumors, 7th ed., Oxford (2009).
12. D. Tan, G. Deeb, J. Wang, et al., Diagn. Mol. Pathol., 12, No. 4, 201-211 (2003).
13. S. Wang, M. Hossein Saboorian, E. P. Frenkel, et al., Mod. Pathol., 15, No. 2, 137-145 (2002).